Working… Menu
Trial record 1 of 1 for:    mc1371
Previous Study | Return to List | Next Study

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma, Gynecological or Other Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02020707
Recruitment Status : Suspended (budget issues)
First Posted : December 25, 2013
Last Update Posted : February 25, 2021
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mayo Clinic

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : February 3, 2022
Estimated Study Completion Date : June 1, 2025